Integrins in bone recognition and metastasis.
Byzova
Tatiana
T
JJ Jacobs Center for Thrombosis and Vascular Biology, Taussig Cancer Center, Lerner Research Institute, Cleveland Clinic Foundation, Cleveland OH 44195, USA. byzovat@ccf.org
D001859:Bone Neoplasms / Q000556:secondary*; D002277:Carcinoma / Q000556:secondary*; D002448:Cell Adhesion / Q000502:physiology; D049109:Cell Proliferation; D006801:Humans; D058574:Integrin-Binding Sialoprotein; D016023:Integrins / Q000037:antagonists & inhibitors / Q000378:metabolism*; D008297:Male; D009362:Neoplasm Metastasis / Q000503:physiopathology*; D015676:Osteonectin / Q000378:metabolism; D011471:Prostatic Neoplasms / Q000473:pathology*; D012795:Sialoglycoproteins / Q000378:metabolism; D015398:Signal Transduction / Q000502:physiology; D014407:Tumor Cells, Cultured; D015854:Up-Regulation / Q000502:physiology; D042461:Vascular Endothelial Growth Factor A / Q000378:metabolism; D040301:Vascular Endothelial Growth Factor Receptor-2 / Q000378:metabolism
C546871:IBSP protein, human; D058574:Integrin-Binding Sialoprotein; D016023:Integrins; D015676:Osteonectin; D012795:Sialoglycoproteins; D042461:Vascular Endothelial Growth Factor A; D040301:Vascular Endothelial Growth Factor Receptor-2